Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2017 May 18;26(6):809–815. doi: 10.1158/1055-9965.EPI-16-0889

Figure 4.

Figure 4

Relative survival by time since diagnosis for women diagnosed with de novo stage IV in the SEER-11 areas in 1992–2007 at ages 15–84 (black) and the adjusted survival for recurrence stage IV for ages 15–84 based on a 1.35 relative risk adjustment (dashed black). The gray curves represent survival from a University of Texas M. D. Anderson Cancer Center (MDACC) study that included women diagnosed with de novo (gray) and recurrence MBC (dashed gray).